SERUM 1,5-ANHYDROGLUCITOL CONCENTRATION IN DIABETIC-PATIENTS RECEIVING A CONTINUOUS SUBCUTANEOUS INFUSION OF INSULIN

被引:0
|
作者
PITKANEN, E
机构
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:171 / 172
页数:2
相关论文
共 50 条
  • [41] OVERNIGHT INSULIN SUBSTITUTION WITH A BEDTIME INJECTION OR CONTINUOUS SUBCUTANEOUS INFUSION IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS
    OLSSON, PO
    ARNQVIST, H
    VONSCHENCK, H
    DIABETOLOGIA, 1987, 30 (07) : A564 - A564
  • [42] Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations
    Sakane, N
    Yoshida, T
    Kogure, A
    Kondo, M
    DIABETES CARE, 1998, 21 (03) : 465 - 465
  • [43] Serum 1,5-anhydroglucitol is a strong predictor of the postprandial hyperglycemia in type 2 diabetes patients
    Kawasaki, I
    Sato, T
    Hosoi, M
    Yoshioka, KS
    Yamakita, T
    Fukumoto, M
    Tanaka, N
    Matsuyama, H
    Ueda, M
    Fujii, S
    DIABETES, 2005, 54 : A76 - A76
  • [44] MORPHOLOGICAL FINDINGS IN PLACENTAE OF INSULIN-DEPENDENT DIABETIC-PATIENTS TREATED WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    LAURINI, RN
    VISSER, GHA
    VANBALLEGOOIE, E
    SCHOOTS, CJF
    PLACENTA, 1987, 8 (02) : 153 - 165
  • [45] Continuous glucose monitoring in type 1 diabetic patients with continuous subcutaneous insulin infusion
    Alves, Marta
    Neves, Celestino
    Varela, Ana
    Arteiro, Cristina
    Pereira, Luis M.
    Carvaiho, Davide
    Medina, Jose L.
    DIABETES, 2008, 57 : A547 - A547
  • [46] Serum 1,5-anhydroglucitol levels inversely correlate with the fibrosis stage in patients with nonalcoholic steatohepatitis
    Nonaka, M.
    Tazuma, S.
    Hyogo, H.
    Kanno, K.
    Inoue, M.
    Nabeshima, Y.
    Iwamoto, K.
    Ishitobi, T.
    Chayama, K.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S358 - S358
  • [47] SERUM 1,5-ANHYDROGLUCITOL (1,5-AG) - NEW CLINICAL MARKER FOR GLYCEMIC CONTROL
    YAMANOUCHI, T
    AKANUMA, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 24 : S261 - S268
  • [48] THE USE OF CONTINUOUS SUBCUTANEOUS OCTREOTIDE INFUSION IN BRITTLE TYPE-1 DIABETIC-PATIENTS
    BELLO, F
    FALKO, JM
    ODORISIO, TM
    OSEI, K
    DIABETIC MEDICINE, 1991, 8 (04) : 385 - 387
  • [49] LOW SUBCUTANEOUS DEGRADATION AND SLOW ABSORPTION OF INSULIN IN INSULIN-DEPENDENT DIABETIC-PATIENTS DURING CONTINUOUS SUBCUTANEOUS INSULIN INFUSION AT BASAL RATE
    CHISHOLM, DJ
    KRAEGEN, EW
    HEWETT, MJ
    FURLER, S
    DIABETOLOGIA, 1984, 27 (02) : 238 - 241
  • [50] Serum 1,5-anhydroglucitol is a potential marker of glycemia for diabetics with nateglinide treatment
    Suzuki, K
    Ueda, H
    DIABETES, 2004, 53 : A465 - A465